January 3 /2013
special feature
Best of the Blog: Pharm Exec’s 10 Most Read Stories of 2013
Happy New Year! We at PharmExec are looking forward to a busy and hopefully fortuitous 2014. Looking back on 2013, here are the 10 most-read stories published on PharmExec’s blog during the year, in case you missed them ... /Read more/ |
social media
Pharm Exec Global Digest Social Media Special
In the latest issue of Pharm Exec Global Digest: Has Pharma Finally ‘Got’ Social Media? — Five Ways Advanced Social Intelligence Can Guide Pharma Strategy — Preparing for Crisis in an ‘Always On’ Digital Word — and more ... /Read more/ |
ZS Associates – Should You Pay the GSK Way?
GSK has been in the news frequently over the past three years with respect to changes in its incentive compensation program.Should you consider a similar plan? |
|
employment survey
Pharma Industry Optimism Outweighs Concerns for Job Security
Amid the environment of a gradual economic recovery and continued consolidation of bio/pharmaceutical companies, scientists, technicians, and professionals involved in drug development expressed muted optimism despite stagnant employment options in Pharmaceutical Technology’s latest employment survey ... /Read more/ |
 |
Global
Europe’s New Clinical Trial Rules: Questions Remains on
Data Transparency
In the latest issue of Pharm Exec Global Digest: Has Pharma Finally ‘Got’ Social Media? — Five Ways Advanced Social Intelligence Can Guide Pharma Strategy — Preparing for Crisis in an ‘Always On’ Digital Word — and more ... /Read more/ |
outsourcing
The Climate Change in Outsourcing
Financial, political, and scientific developments that began 10 years ago may have only just begun to affect the bio/pharma contract services industry, writes Jim Miller ... /Read more/ |
| also in this issue
The Future of the Clinical Immunodiagnostics Market
DIY Healthcare Tops PwC’s Health Industry Issues for 2015
Pharm Exec’s 2015 Pipeline Report
Pharm Exec eBooks Available as Apps
|
industry update
- Agilis Biotherapeutics (New York, NY) named George S. Zorich as the company’s new Chief Executive Officer.
- ImmunoGen, Inc. (Waltham, MA) appointed David Johnston as Chief Financial Officer.
- Halozyme Therapeutics, Inc. (San Diego, CA) announced that Helen Torley will be joining as President and Chief Executive Officer on January 6.
- Wendell Wierenga, Ph.D, was appointed to the Board of Directors of Ocera Therapeutics, Inc. (Palo Alto, CA).
|
